No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Annovis Bio Advances Alzheimer's and Parkinson's Drug Trials
Express News | Annovis Bio Inc - to Offer up to $50 Million in Common Stock
Express News | Annovis Bio Inc - Enters Equity Distribution Agreement With Oppenheimer
Annovis Bio Appoints William Fricker as Interim CFO
Express News | Annovis Bio Inc - Appoints William Fricker as Interim CFO
Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today's Marketplace
Unlock the Full List